The Management of Phaeochromocytomas and Paragangliomas in the Era of Precision Medicine: Where Are We Now? Evidence-Based Systemic Treatment Options and Future Cluster Oriented Perspectives

The Management of Phaeochromocytomas and Paragangliomas in the Era of Precision Medicine: Where Are We Now? Evidence-Based Systemic Treatment Options and Future Cluster Oriented Perspectives

Pheochromocytomas (PCCs) and Paragangliomas (PGLs), commonly known as PPGLs to include both entities, are rare neuroendocrine tumors that may arise in the context of hereditary syndromes or be sporadic. However, even among sporadic PPGLs, identifiable somatic alterations in at least one of the known...

Full description

Bibliographic Details
Main Authors: Alessandra Bracigliano, Antonella Lucia Marretta, Luigi Pio Guerrera, Roberto Simioli, Ottavia Clemente, Vincenza Granata, Anita Minopoli, Giuseppina Della Vittoria Scarpati, Fernanda Picozzi, Lucia Cannella, Antonio Pizzolorusso, Francesca Di Gennaro, Roberto Tafuto, Maria Rosaria Sarno, Ernesta Cavalcanti, Dario Ribera, Salvatore Tafuto
Format: Article
Language:English
Published: MDPI AG 2024-03-01
Series:Pharmaceuticals
Subjects:
phaeochromocytomas
paragangliomas
neuroendocrine tumors
molecular clusters
management
cluster-specific approach
Online Access:https://www.mdpi.com/1424-8247/17/3/354

Internet

https://www.mdpi.com/1424-8247/17/3/354

Similar Items